ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

MNPR Monopar Therapeutics Inc

0.734
0.074 (11.21%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Monopar Therapeutics Inc MNPR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.074 11.21% 0.734 13:00:03
개장가 저가 고가 종가 전일 종가
0.67 0.6433 0.7624 0.7272 0.66
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202421:00GLOBEMonopar Announces Radiopharma Presentation Selected for..
16/04/202421:00GLOBEMonopar Announces Filing of Patent Protecting MNPR-101..
10/04/202421:00GLOBEMonopar Initiates Radiopharma Phase 1 Clinical Trial for..
28/03/202420:00GLOBEMonopar Reports Fourth Quarter and Full-Year 2023 Financial..
07/03/202422:30EDGAR2Form 8-K - Current report
05/03/202421:00EDGAR2Form 8-K - Current report
05/03/202421:00GLOBEMonopar Announces Positive Preclinical Therapeutic Isotope..
29/02/202403:45EDGAR2Form 8-K - Current report
27/02/202421:00GLOBEMonopar Provides Update on MNPR-101-Zr Radiopharma Clinical..
27/02/202420:59EDGAR2Form 8-K - Current report
22/02/202421:00EDGAR2Form 8-K - Current report
22/02/202421:00GLOBEMonopar Announces Promising Preclinical Data for its..
20/02/202422:00EDGAR2Form 8-K - Current report
20/02/202422:00GLOBEMonopar Receives Clearance to Proceed with First-in-Human..
04/01/202409:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202409:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202321:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:00EDGAR2Form 8-K - Current report
09/11/202321:00GLOBEMonopar Therapeutics Reports Third Quarter 2023 Financial..
01/11/202320:00EDGAR2Form 8-K - Current report
01/11/202320:00GLOBEMonopar Presents Data Showing Tumor Reduction Benefit of..
10/10/202320:00GLOBEMonopar to Participate in the Roth MKM 2023 Healthcare..
04/10/202308:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/09/202320:00GLOBEMonopar to Participate in the H.C. Wainwright 25th Annual..
31/08/202306:16EDGAR2Form 8-K - Current report
10/08/202320:00EDGAR2Form 8-K - Current report
10/08/202320:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:00GLOBEMonopar Therapeutics Reports Second Quarter 2023 Financial..
08/08/202320:00EDGAR2Form 8-K - Current report
08/08/202320:00GLOBEMonopar Provides Encouraging Camsirubicin Clinical Data..
11/07/202320:00EDGAR2Form 8-K - Current report
11/07/202320:00GLOBEMonopar Announces MNPR-101 Radiopharma Collaboration..
04/07/202307:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/07/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202305:13EDGAR2Form 8-K - Current report
21/06/202320:00GLOBEMonopar to Participate in the Radiopharma Forum by the Lake..
14/06/202320:00GLOBEMonopar to Participate in the Maxim Group’s Healthcare..
01/06/202320:00GLOBEMonopar Announces Encouraging Camsirubicin Phase 1b Trial..
11/05/202320:00GLOBEMonopar Therapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock